An app based around artificial intelligence (AI) aims to help patients in countries with developing healthcare systems understand their symptoms and find appropriate treatment.
Pfizer’s Mylotarg has been approved by the English and Scottish NHS cost watchdogs as a restricted use treatment for a certain type of acute myeloid leukaemia (AML).
Healthcare data is everywhere and more is coming – data from wearables, data from Internet of Things devices, genomic data, and ‘omics’ data more broadly.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
